The Combination of Cell Cultured Technology and In Silico Model to Inform the Drug Development
Human-derived in vitro models can provide high-throughput efficacy and toxicity data without a species gap in drug development. Challenges are still encountered regarding the full utilisation of massive data in clinical settings. The lack of translated methods hinders the reliable prediction of clin...
Main Authors: | Zhengying Zhou, Jinwei Zhu, Muhan Jiang, Lan Sang, Kun Hao, Hua He |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/5/704 |
Similar Items
-
Kidney Organoid and Microphysiological Kidney Chip Models to Accelerate Drug Development and Reduce Animal Testing
by: Wei-Yang Chen, et al.
Published: (2021-07-01) -
Disposition and effect of intra-articularly administered dexamethasone on lipopolysaccharide induced equine synovitis
by: Carl Ekstrand, et al.
Published: (2019-06-01) -
In Vitro Systems for Studying Different Genotypes/Sub-Genotypes of Hepatitis B Virus: Strengths and Limitations
by: Constance N. Wose Kinge, et al.
Published: (2020-03-01) -
Recurrent Urinary Tract Infection: A Mystery in Search of Better Model Systems
by: Benjamin O. Murray, et al.
Published: (2021-05-01) -
Human Microphysiological Systems and Organoids as in Vitro Models for Toxicological Studies
by: George A. Truskey
Published: (2018-07-01)